The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
about
The immunologic effects of estrogen on psoriasis: A comprehensive review.What is new in therapy?Potential new drugs for therapy of chronic obstructive pulmonary disease.Emerging drugs in psoriasis.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases
P2860
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@ast
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@en
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@nl
type
label
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@ast
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@en
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@nl
prefLabel
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@ast
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@en
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@nl
P2093
P2860
P356
P1476
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.1.95
P407
P577
2000-01-01T00:00:00Z